Stay updated on PD-1 Inhibitor Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.

Latest updates to the PD-1 Inhibitor Combo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page adds new help/navigation items and a recruitment-status notice, and updates the revision label from v3.5.5 to v3.6.0, with a small formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision from v3.5.4 to v3.5.5 indicates a minor update to the page's revision history for the study record. It does not alter the study details or eligibility criteria.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag changed from v3.5.3 to v3.5.4 on the page, reflecting a new software release. The update appears to be a platform-level change and does not alter the study details or their presentation.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s footer/interface revision version was updated from v3.5.0 to v3.5.3, indicating a change to the site release rather than to the clinical trial information.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.4.3 was added to the page, replacing v3.4.2.SummaryDifference0.0%

Stay in the know with updates to PD-1 Inhibitor Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.